Influenza Trials in Oulu, Finland
Conditions / Influenza / Oulu, Finland
Research into Influenza spans multiple therapeutic approaches and trial phases.
12 total trials for this combination
Showing top 10 of 12 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05569239 | Efficacy, Immunogenicity and Safety of OVX836 Influenza Vaccine 480μg | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT02583256 | Clinical Study to Evaluate Safety, Immunogenicity of Investigational Flu Vaccine Compared to an Approved Flu Vaccine in Children Previously Vaccinated in Trial V118_05 (NCT01964989) | COMPLETED | PHASE3 |
| NCT03684044 | Study to Assess Efficacy and Safety of Baloxavir Marboxil In Combination With Standard-of-Care Neuraminidase Inhibitor In Hospitalized Participants With Severe Influenza | COMPLETED | PHASE3 |
| NCT00321373 | Study to Evaluate an Influenza Vaccine Candidate | COMPLETED | PHASE2 |
| NCT00884182 | Safety and Immunogenicity of an Intramuscular A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine in Children | COMPLETED | PHASE2 |
| NCT00630331 | Efficacy Study of Two Influenza Vaccines and Placebo in Healthy Adult Subjects | COMPLETED | PHASE3 |
| NCT00645411 | Pediatric Safety and Immunogenicity Study of Cell-Culture Derived and Egg-based Subunit Influenza Vaccines in Healthy Children and Adolescents | COMPLETED | PHASE2/PHASE3 |
| NCT03301051 | Efficacy, Safety, and Immunogenicity of a Plant-Derived Quadrivalent Virus-Like Particles (VLPs) Influenza Vaccine in Adults | COMPLETED | PHASE3 |
| NCT00956046 | A Study of Swine-origin A/H1N1 Influenza Vaccines in Healthy Europeans Children Aged 6 to 35 Months | COMPLETED | PHASE2 |
| NCT00363870 | A Study to Demonstrate the Efficacy of GSK Biologicals' Influenza Vaccine in Adults | COMPLETED | PHASE4 |